TETRALOGIC PHARMACEUTICALS CORP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
TETRALOGIC PHARMACEUTICALS CORP reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $12.65 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-16.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2016-03-16
- TETRALOGIC PHARMACEUTICALS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2014-12-31 was $0.00.
- TETRALOGIC PHARMACEUTICALS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2014-09-30 was $41.37K.
- TETRALOGIC PHARMACEUTICALS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2014 was $12.65K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $41.37K derived: sum of 2 quarters · filed 2016-03-16 | $12.65K 10-K · filed 2016-03-16 | ||
| 2014-09-30 | $41.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $12.65K 10-Q · filed 2015-11-04 | -$41.37K 10-Q · filed 2014-11-05 | ||
| 2014-06-30 | -$28.72K 10-Q · filed 2014-08-05 |